Snowball logo
logo
EVMN

Evommune, Inc.

EVMN NYSE
$13.79+$0.12  (0.88%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
202320242025TTM
Revenue
Total revenue
571310
COGS
11.2871.389-
Gross Profit
45.71313-
Operating Expenses & Income
Operating Income
(37.85)(70.01)(81.07)(101.9)
Total Operating Expenses
41.8575.7394.07111.5
R&D Expenses
3264.2474.0483.77
Selling General & Admin Expenses
--20.0325.98
Earnings from Continuing Operations
Interest Expense
(0.058)(0.034)(0.007)-
Interest Income
--3.3237.24
Income Tax Expense
----
Net Income
Net Income
(34.05)(66.81)(68.87)(94.67)
Supplemental
EBIT
(33.99)(66.77)(68.87)-
EBITDA
(32.99)(65.49)(67.48)-
In millions of USD, except % and values per 1 share